Investors considering a purchase of Spyre Therapeutics Inc (Symbol ... Collecting that bid as the premium represents a 6.8% return against the $12.50 commitment, or a 13.5% annualized rate ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback